https://www.selleckchem.com/pr....oducts/tetramisole-h
01) increase in odds of achieving fibrosis improvement with no NASH worsening. Weight gain was associated with worsening of disease activity. For every kg of weight lost, the odds of fibrosis improving were 5% (95% CI, 2%-8%; P=.001). There was no evidence that the association between weight change and outcome depended upon pharmacological treatment, trial, body mass index, and baseline fibrosis. Weight change was independently and monotonically associated with changes in biochemical and histological features of NASH. Guidelines
Like
Comment
Share
